Capital Research Global Investors 13D/13G Filings for Gilead Sciences, Inc. (GILD)

Capital Research Global Investors 13D and 13G filings for Gilead Sciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-13
3:32 pm
Sale
2023-02-1413GGILEAD SCIENCES INC
GILD
Capital Research Global Investors54,602,952
4.400%
-52,554,029decrease
(-49.04%)
Filing
2022-02-11
12:22 pm
Sale
2022-02-1413GGILEAD SCIENCES INC
GILD
Capital Research Global Investors107,156,981
8.500%
-14,515,418decrease
(-11.93%)
Filing